glp 1 hospitalization Increased Risk of Heart Failure With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials Study links GLP-1 drugs to

Total Cholesterol (TC)

Sodium is a chemical element that occurs in salt and many foods

In people struggling with weight, this signal is often weak or delayed, leading to overeating and energy imbalance

Combined formulations containing a liraglutide nanoformulation and an SGLT-2 inhibitor have been shown to significantly improve blood lipid profiles in patients with type 2 diabetes

Pfizers dose-optimization studies of once-daily formulations of danuglipron (NCT06567327 and NCT06568731) met key pharmacokinetic objectives and confirmed a formulation and dose with the potential to deliver a competitive efficacy and tolerability profile in Phase 3 testing, based on earlier studies of twice-daily danuglipron